Combinatory Therapy Antimicrobial Peptide-Antibiotic to Minimize the Ongoing Rise of Resistance
Main Authors: | Luis R. Pizzolato-Cezar, Nancy M. Okuda-Shinagawa, M. Teresa Machini |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-08-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmicb.2019.01703/full |
Similar Items
-
Aerobic bacterial profile and antibiotic resistance in patients with diabetic foot infections
by: Michele Cezimbra Perim, et al.
Published: (2015-10-01) -
Prevalence of antibiotic-resistant organisms among hospitalized patients at a tertiary care center in Lebanon, 2010–2018
by: Moustafa Moussally, et al.
Published: (2021-01-01) -
Prevalence of multidrug-resistant organisms in refugee patients admitted to a German university hospital depending on duration of stay in Germany
by: Reinheimer, Claudia, et al.
Published: (2019-06-01) -
Evaluation of the Antimicrobial Peptide, RP557, for the Broad-Spectrum Treatment of Wound Pathogens and Biofilm
by: Kathryn Wynne Woodburn, et al.
Published: (2019-07-01) -
Predicting the occurrence of multidrug-resistant organism colonization or infection in ICU patients: development and validation of a novel multivariate prediction model
by: Li Wang, et al.
Published: (2020-05-01)